X

Other Industries

ConocoPhillips in talks to sell stake in Cenovus Energy

US oil producer ConocoPhillips (COP) is working towards dumping the stake it acquired last year in Calgary-based oil company Cenovus…

Athenahealth CEO leaves; company ponders sale

Jonathan Bush, the chief of Athenahealth (ATHN), has stepped down from his role with immediate effect. The company has begun…

Watch out Amgen! Mylan wins FDA approval for biosimilar of Neulasta

Mylan (MYL) celebrates the Food and Drug Administration's go-ahead signal for its first biosimilar infection-fighting treatment Neulasta manufactured by Amgen…

Twitter finally makes its way to the S&P 500

The struggling social media company Twitter (TWTR) will finally become a part of the S&P 500 index, effective before the…

Monsanto all set to disappear into Bayer

Bayer AG plans to close its $63-billion acquisition of Monsanto Company (MON) by this Thursday. Bayer said it would keep…

General Electric needs a well-engineered solution to get back into shape

A freefalling stock and progressively shrinking dividend are something investors dread the most, and things turn really depressing when it…

Pfizer’s blockbuster drug Xeljanz snags FDA approval for ulcerative colitis

Pfizer’s (PFE) blockbuster drug Xeljanz has won itself a new regulatory approval to treat adults with inflammatory bowel disease (IBD).…

PVH earnings climb on Tommy Hilfiger and Calvin Klein businesses’ strength

PVH Corp (PVH) reported a 155% jump in earnings for the first quarter helped by broad-based strength across its businesses…

Bayer-Monsanto merger finalized after years of pursuit

The days of waiting for Bayer is finally over. The Germany based pesticide firm has crossed the final hurdle in…

Allergan to sell women’s health and infectious disease units

Allergan Plc (AGN) is planning to sell its women’s health and infectious disease businesses after completing its strategic review. The…